isabelobrien, Author at European Medical Journal - Page 43 of 70

Type 2 diabetes among the world's five most researched diseases

Type 2 diabetes has replaced COVID-19 on the list of the world’s most studied diseases this year, according to a study by Phesi.

Three women holding babies on green background

New drug could increase odds of IVF success

A breakthrough fertility drug that could improve the chances of IVF success has announced positive Phase 2 results.

Sandoz’s Claire D’Abreu-Hayling on leading with love

Claire D’Abreu-Hayling, Chief Scientific Officer, Sandoz, shares how leading with love rather than ruling with an iron first is the best way to get results.

Spoonful of technology: May-June 2024

Explore the top tech stories that have shaped pharma in recent months as we explore implants to AI models, with a particular focus on antimicrobial resistance.

Spotlight: June 2024

Discover June’s top pharma news in our monthly round-up. From the latest market predictions to new vaccine development initiatives, there’s plenty to discover.

GLP-1 treatments may lower cancer risk in type 2 diabetes patients

A new study finds that patients with type 2 diabetes taking GLP-1 treatments have a reduced chance of developing obesity-related cancers.

How creativity and innovation are revolutionising medical education

Isabel is joined by Tim Uden, Creative Director, EMJ to discuss the new frontier of medical education tools and skills – interactive content.

Pride 2024: How can pharma leaders make a difference?

Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.

Pride Special: J&J's Edmond Chan on the value in being your authentic self

J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community

Phone in someone's hand with medical imagery on it

From basic to bold: Introducing interactive medical education

A 3D, interactive approach allows pharmaceutical companies to share the latest medical breakthroughs in a more dynamic and engaging way.